In November 2011, the Office of Inspector General (“OIG”) initiated a study regarding the use of atypical antipsychotic drugs in nursing homes. The findings from the study indicated these types of drugs were being overprescribed to high-risk nursing home residents suffering from dementia; were being prescribed for uses not approved by the FDA; and... READ MORE
Centers for Medicare & Medicaid Services (“CMS”) Acts to Improve Dementia Care in Nursing Homes
Posted on June 5, 2013 in Long-Term Care, Home Health & Hospice
Written by: Selby, Todd J.